Clinical trials have demonstrated that patients using semaglutide 2.4 mg weekly can achieve average weight loss of approximately 15% of body weight over 68 weeks when combined with lifestyle modifications
Acknowledgments We express our gratitude to BioRender (www.BioRender.com) for their graphical assistance during the preparation of this manuscript
These medications, once primarily diabetes drugs to manage blood glucose levels, now stand as backbone therapies for complex cardiometabolic conditions
If these are ineffective, pregabalin or gabapentin may be offered as alternatives
Maybe thats reading up on the official medicine information, booking a conversation with your GP, reviewing your eating routine, or adding a realistic movement habit you can actually keep
They are not required to demonstrate efficacy before marketing, unlike licensed medications